Neurology News and Research

Latest Neurology News and Research

BrainStorm publishes NurOwn ALS Phase 2 randomized clinical trial results in Neurology

BrainStorm Cell Therapeutics Inc., a leader in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, today announced publication of "NurOwn Phase 2 Randomized Clinical Trial in ALS: Safety, Clinical and BioMarker Results," in the international, peer-reviewed journal Neurology.

20 Nov 2019

Six ways physicians can help optimize reproductive health in women with epilepsy

Worldwide, more than 15 million women of childbearing age have epilepsy. Each year about 600,000 of them become pregnant.

20 Nov 2019

Atlantic Health System offers advanced lung cancer screening program

November is national Lung Cancer Awareness Month. Lung cancer remains the #1 cancer killer of both men and women in the United States.

20 Nov 2019

Scientists discover new molecular drivers of Parkinson's disease

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis.

20 Nov 2019

Study of 'face blindness' provides clues to what goes wrong in the brain

People with prosopagnosia, or "face blindness," have trouble recognizing faces -- even those of close friends and family members.

19 Nov 2019

New collaboration aims to advance early childhood development

Mount Sinai Kravis Children's Hospital announced today that it has partnered with the Bezos Family Foundation and Vroom, the Foundation's early learning program.

19 Nov 2019

Self-destructive mitochondria may set the stage for neurodegeneration in ALS

Northwestern Medicine scientists have discovered a new phenomenon in the brain that could explain the development of early stages of neurodegeneration seen in diseases such as ALS, which affects voluntary muscle movement such as walking and talking.

18 Nov 2019

Dementia risk perception vis-a-vis actual action among Americans

A study has shown that one in two Americans between age 50 and 64 years is aware of the risk of development of dementia with age but only 5 percent are actually visiting their healthcare providers to seek preventive and therapeutic attention.

17 Nov 2019

Researchers evaluate potential of FMT, pre- and probiotics to treat Parkinson's patients

Constipation is a common complaint in patients with Parkinson's disease. Fecal microbiome transplantation and pre- and probiotics are potential options for treating constipation and restoring the microbiome of patients with Parkinson's disease, but scientists warn that clinical data are scarce, and more research is needed before supporting their use.

15 Nov 2019

Modern resuscitation science: Illuminating the complex processes of death

On Monday, November 18, 2019 the New York Academy of Sciences and the Critical Care and Resuscitation Research Program at NYU Langone will present a two part event titled What Happens When We Die? at the Academy's offices in downtown Manhattan.

15 Nov 2019

New study reveals perception of dementia risk, preventive actions among middle-aged Americans

Nearly half of Americans in their 50s and early 60s think they're likely to develop dementia as they grow older, but only 5% of them have actually talked with a doctor about what they could do to reduce their risk, a new study finds.

15 Nov 2019

Alzheimer's Association's funding enables expansion of aging study in longest running birth cohort

The Alzheimer's Association and University College London are partnering to study brain aging and dementia in 500 individuals whose health and health-related behaviors have been documented since birth.

14 Nov 2019

Study finds sex differences in treatment and outcome after stroke

Women are more likely to survive a stroke, but have worse disability and poorer quality of life afterwards compared to men, according to research published in the latest issue of Neurology, the medical journal of the American Academy of Neurology.

14 Nov 2019

People who are illiterate may have greater risk of developing dementia

New research has found that people who are illiterate, meaning they never learned to read or write, may have nearly three times greater risk of developing dementia than people who can read and write.

13 Nov 2019

Substantial changes in blood pressure over long term linked to dementia risk

In a new research study published in the open access journal PLOS Medicine, Albert Hofman and colleagues at Erasmus MC University Medical Center, Rotterdam, the Netherlands and Harvard T.H. Chan School of Public Health, Boston, United States report that people who experienced substantial changes in blood pressure over the long term were at greater risk of dementia than those who did not.

13 Nov 2019

Certain brain regions must be intact in stroke survivors with aphasia for successful speech entrainment

In an article in Brain, researchers at the Medical University of South Carolina (MUSC) and elsewhere report which brain regions must be intact in stroke survivors with aphasia if they are to perform well in a speech entrainment session, successfully following along with another speaker.

12 Nov 2019

SleepFit app can help monitor motor symptoms in patients with Parkinson's disease

In order to optimally treat motor symptoms in patients with Parkinson's disease (PD), it is necessary to have a good understanding of their severity and daily fluctuations. A report in the Journal of Parkinson's Disease describes how a new app, SleepFit, could be a useful tool in routine clinical practice to monitor motor symptoms and facilitate specific symptom-oriented follow-up.

12 Nov 2019

Popular cancer drug linked to weight gain and increased systolic blood pressure

New recommendations aim to improve outcomes of Parkinson's disease patients

Since the discovery that the gut microbiome may play a role in the development of Parkinson's disease (PD), this fresh scientific approach has produced varying results. In this review published in the Journal of Parkinson's Disease scientists compare results of current research and provide recommendations to increase the comparability and utility of these studies with a view towards improving patient outcomes.

11 Nov 2019

Adult SMA patients treated with Nusinersen show improvement in motor function

A study published in the Journal of Neuromuscular Diseases presents the first evidence of mild improvement or stabilization of motor and respiratory function in adults with spinal muscular atrophy type 3 (SMA3) treated with Nusinersen, which was the case even in patients who have had the disease for 20 years or more.

11 Nov 2019